stockrowEton Pharmaceuticals, Inc. (ETON) vs Harrow, Inc. (HROW)
- Eton Pharmaceuticals, Inc. ETON 57.40 +21.74%
- Harrow, Inc. HROW 26.62 +2.23%
Eton Pharmaceuticals, Inc. and Harrow, Inc. are both Drug Manufacturers Specialty & Generic companies. Eton Pharmaceuticals, Inc. is the larger, with a market value of $1.4B against $976.2M — 1.4× the size. Harrow, Inc. has negative trailing earnings, so its P/E is not meaningful; Eton Pharmaceuticals, Inc. trades at 26.8×. Eton Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 100.6% against 21.1%. Eton Pharmaceuticals, Inc. has the higher net margin (35.4% vs −13.5%) and the higher return on invested capital (46.8% vs −0.77%). Across the 19 metrics below, Eton Pharmaceuticals, Inc. leads on 14 and Harrow, Inc. on 5.
Valuation
Profitability
| Metric | ETON | HROW | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 69.15% | 73.28% | 53.51% |
| Operating margin | 28.84% | (1.00%) | 0.00% |
| Net margin | 35.35% | (13.51%) | (2.45%) |
| Free cash flow margin | 14.17% | (4.75%) | 0.00% |
| Return on equity | 90.62% | (116.07%) | (0.80%) |
| Return on assets | 38.10% | (9.77%) | (1.67%) |
| Return on invested capital | 46.77% | (0.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack